Bellevue Group AG

SEC CIK: 0001674546
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

SLN holding history

Silence Therapeutics plc in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SLN overview All 13F holders of SLN Full Q2 2026 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2021

Holdings of SLN by Bellevue Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−30,483−100.0%	Sold out	Holders
Q2 2022	30,483	$361.0K	<0.1%	−16,183−34.7%	Reduced	Holders
Q1 2022	46,666	$887.0K	<0.1%	00.0%	Unchanged	Holders
Q4 2021	46,666	$1.09M	<0.1%	+46,666	New	Holders